<DOC>
	<DOCNO>NCT00630123</DOCNO>
	<brief_summary>To investigate change brain derive neurotrophic factor ( BDNF ) pre post treatment patient depression either ECT TMS .</brief_summary>
	<brief_title>Effect Electroconvulsive Therapy ( ECT ) Transcranial Magnetic Stimulation ( TMS ) Brain Derived Neurotrophic Factor ( BDNF ) Depressed Patients .</brief_title>
	<detailed_description />
	<criteria>MDD bipolar disorder ; current depressive episode , hamd17 &gt; 17 ymrs &lt; 8 ; recommend receive ECT TMS part clinical care ; male/female ; age 1865 ; inpatient outpatient ; comorbid dysthymic disorder , gad , social anxiety include ; able give write consent agree . current manic , hypomanic , mixed episode , ymrs &gt; 7 ; current schizophrenia , anorexia , bulimia , substance dependence ( current within past 6 month exclude caffeine nicotine ) ; TMS ECT last 3 month ; primary diagnosis ; uncontrolled medical illness ; epilepsy severe personality disorder discretion investigator ; 3 week prior first blood test , antidepressant , mood stabilizer , antipsychotic add increase ; pregnant woman woman childbearing potential willing use appropriate contraception , nurse woman ; know intolerance lack response treatment receive judged investigator ; medical condition would affect serum level BDNF ; involvement planning conduct study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>